Evidence map›Paper›PMID 42649924›Full record

ArticleCancers2026

Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients.

Diana Luísa Almeida-Nunes, Ana Mendes-Frias, Mariana Nunes, Verónica Ferreira, Cláudia Lobo, Paula Monteiro, Miguel Henriques Abreu, Carla Bartosch, Claudia Nobrega, Ricardo Jorge Dinis-Oliveira and 2 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Diana Luísa Almeida-NunesAssociate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0003-4270-7701
Ana Mendes-FriasLife and Health Sciences Research Institute (ICVS), School of Medicine from University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-7561-5347
Mariana NunesDifferentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-4733-5778
Verónica FerreiraDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Cláudia LoboDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Paula MonteiroDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.ORCID 0000-0002-3482-2307
Miguel Henriques AbreuDepartment of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Carla BartoschDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Claudia NobregaLife and Health Sciences Research Institute (ICVS), School of Medicine from University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-0282-9619
Ricardo Jorge Dinis-OliveiraAssociate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0001-7430-6297
Ricardo SilvestreLife and Health Sciences Research Institute (ICVS), School of Medicine from University of Minho, 4710-057 Braga, Portugal.
Sara RicardoAssociate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0003-4091-2226

Funding

Cooperativa de Ensino Superior Politécnico e Universitário ImmunoT4OC_GI2- CESPU-2023Cooperativa de Ensino Superior Politécnico e Universitário upPTXo-vcar-GI2-CESPU-2022Fundação para a Ciência e Tecnologia 2020.04720.BD-DOI: 10.54499/2020.04720.BDFundação para a Ciência e Tecnologia 2021.05081.BD-DOI: 10.54499/2021.05081.BDFundação para a Ciência e Tecnologia 2021.07836.BD-DOI: 10.54499/2021.07836.BDFundação para a Ciência e Tecnologia contract10.54499/2020.00185.CEECIND/CP1600/CT0004Fundação para a Ciência e Tecnologia LA/P/0050/2020 (DOI 10.54499/LA/P/0050/2020)Fundação para a Ciência e Tecnologia UIDB/50026/2020 (DOI 10.54499/UIDB/50026/2020)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-PD-1high-grade serous carcinomamalignant ascitic fluidT cell exhaustion-like phenotypetumor immune microenvironment

Identifiers

PMID42649924
PMCPMC13511107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.